Who owns INVO BIOSCIENCE INCORPORATED COM NEW?
- Ticker: INVO
- CUSIP Number: 44984f401
Tip: Access positions for across all investors
Analyze quarterly positions in Invo Bioscience Incorporated with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Invo Bioscience Incorporated stock
Who bought or sold INVO BIOSCIENCE INCORPORATED COM NEW this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 54k | $61k | 0% | Mar 2024 |
|
| Geode Capital Management | 25k | $27k | 73% | Mar 2024 |
|
| UBS Group | 8.1k | $9.2k | 13% | Mar 2024 |
|
| Tower Research Capital | 6.9k | $7.8k | 158% | Mar 2024 |
|
| Advisor Group Holdings | 559.00 | $632.005400 | 0% | Mar 2024 |
|
| Royal Bank of Canada | 538.00 | $999.980600 | 0% | Mar 2024 |
|
| Aspire Private Capital | 115.00 | $129.996000 | 0% | Mar 2024 |
|
| Morgan Stanley | 37.00 | $41.998700 | -10% | Mar 2024 |
|
| Wells Fargo & Company | 18.00 | $19.999800 | 6% | Mar 2024 |
|
| Gleason Group | 3.00 | $3.000000 | 0% | Mar 2024 |
|
Who sold out of Invo Bioscience Incorporated?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| BlackRock | Sep 2023 | 24.00 | $19.000800 |